Product Images Venlafaxine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 55700-813 by Quality Care Products, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 01

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 01

This is a list of drugs and their interaction with CYP2D6 EM's and PM's, as well as their effects on the analyte venlafaxine. There are also PK Fold Change and 90% C| recommendations provided. The recommendations include avoiding concomitant use, using with caution in certain patient populations, and monitoring blood pressure.*

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 02

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 02

This is a list of drugs and their potential interaction with other drugs. Each drug is listed with several analytes, and the PKFold Change and 90% CRecommendation are provided. The text also includes guidance on concomitant use, dosing adjustment, and monitoring for each drug.*

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 03

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 03

This text appears to be a table that includes information about special populations and their response to the drug venlafaxine. It mentions the analyte, PK parameters, and fold change with 90% CI, as well as recommendations for individuals in different special populations. These populations include individuals with hepatic impairment, renal impairment, CYP2D8 polymorphism, those over 80 years of age, and females/males. The table recommends reduced dosing for some populations and individualization of dosing may be necessary.*

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 04

Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 04

The text can be divided into three parts: 1. "eHCI" and "H4C0 C": These are not recognizable words or phrases and it is not clear what they might refer to. 2. "Venlafaxine hydrochloride": This is a chemical compound used as an antidepressant and for the treatment of anxiety disorders. Therefore, the only useful description that can be generated from the given text is: "Venlafaxine hydrochloride is a chemical compound used as an antidepressant and for the treatment of anxiety disorders. The other parts of the text are not recognizable or meaningful."*

image description - New Doc 2019 11 14 15.32.47 1

image description - New Doc 2019 11 14 15.32.47 1

This is a description of a medication named Venlafaxine HCl ER 75 MG. It is produced by Cadila Healthcare Ltd. in India and distributed in the United States by Zvdus Pharmaceuticals USA Inc. The medication comes in an orange-white capsule with the imprint ZA36;75;MG. It is important to keep it out of children's reach and store it at 68-77 degrees F. Before using it, it's recommended to consult with a physician and read the manufacturer's insert. The product has a GTIN of 00355700813307, a serial number of R, a let of 3, and an expiration date of /f R only.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.